{"creationDateTime": "2023-07-31T14:46:36", "datasetJSONVersion": "1.0.0", "fileOID": "www.cdisc.org/StudyMSGv2/1/Define-XML_2.1.0.TI", "originator": "CDISC MSG Team", "referenceData": {"studyOID": "cdisc.com/CDISCPILOT01", "metaDataVersionOID": "MDV.MSGv2.0.SDTMIG.3.3.SDTM.1.7", "itemGroupData": {"TI": {"records": 62, "name": "TI", "label": "Trial Inclusion/Exclusion Criteria", "items": [{"OID": "ITEMGROUPDATASEQ", "name": "ITEMGROUPDATASEQ", "label": "Record identifier", "type": "integer"}, {"OID": "IT.TI.STUDYID", "name": "STUDYID", "label": "Study Identifier", "type": "string", "length": 12, "keySequence": 1}, {"OID": "IT.TI.DOMAIN", "name": "DOMAIN", "label": "Domain Abbreviation", "type": "string", "length": 2}, {"OID": "IT.TI.IETESTCD", "name": "IETESTCD", "label": "Incl/Excl Criterion Short Name", "type": "string", "length": 7, "keySequence": 2}, {"OID": "IT.TI.IETEST", "name": "IETEST", "label": "Inclusion/Exclusion Criterion", "type": "string", "length": 196}, {"OID": "IT.TI.IECAT", "name": "IECAT", "label": "Inclusion/Exclusion Category", "type": "string", "length": 9}, {"OID": "IT.TI.TIVERS", "name": "TIVERS", "label": "Protocol Criteria Versions", "type": "string", "length": 200, "keySequence": 3}], "itemData": [[1, "CDISCPILOT01", "TI", "INCL01", "Males and postmenopausal females at least 50 years of age.", "INCLUSION", "ORIGINAL"], [2, "CDISCPILOT01", "TI", "INCL02", "Diagnosis of probable AD as defined by NINCDS and the ADRDA guidelines.", "INCLUSION", "ORIGINAL"], [3, "CDISCPILOT01", "TI", "INCL03", "MMSE score of 10 to 23.", "INCLUSION", "ORIGINAL"], [4, "CDISCPILOT01", "TI", "INCL04", "Modified Hachinski Ischemic Scale score of <= 4.", "INCLUSION", "ORIGINAL"], [5, "CDISCPILOT01", "TI", "INCL05", "CNS imaging (CT scan or MRI of brain) compatible with AD within past 1 year. (See Protocol for incompatible findings.)", "INCLUSION", "ORIGINAL"], [6, "CDISCPILOT01", "TI", "INCL06", "Investigator has obtained informed consent signed by the patient (and/or legal representative) and by the caregiver.", "INCLUSION", "ORIGINAL"], [7, "CDISCPILOT01", "TI", "INCL07", "Geographic proximity to investigator's site that allows adequate follow-up.", "INCLUSION", "ORIGINAL"], [8, "CDISCPILOT01", "TI", "INCL08", "Caregiver will monitor administration of prescribed medications, and will be responsible for the overall care of the patient at home.", "INCLUSION", "ORIGINAL"], [9, "CDISCPILOT01", "TI", "EXCL09", "Persons who have previously completed or withdrawn from this study or any other investigating xanomeline TTS or the oral formulation of Zanomaline.", "EXCLUSION", "ORIGINAL"], [10, "CDISCPILOT01", "TI", "EXCL10", "Use of any investigational agent or approved Alzheimer's therapeutic medication within 30 days prior to enrollment into the study.", "EXCLUSION", "ORIGINAL"], [11, "CDISCPILOT01", "TI", "EXCL11", "Serious illness which required hospitalization within 3 months of screening.", "EXCLUSION", "ORIGINAL"], [12, "CDISCPILOT01", "TI", "EXCL12", "Diagnosis of serious neurological conditions (See Protocol)", "EXCLUSION", "ORIGINAL"], [13, "CDISCPILOT01", "TI", "EXCL13", "Episode of depression meeting DSM-IV criteria within 3 months of screening.", "EXCLUSION", "ORIGINAL"], [14, "CDISCPILOT01", "TI", "EXCL14", "A history within the last 5 years of the following: a) Schizophrenia b) Bipolar Disease c) Ethanol or psychoactive drug abuse or dependence.", "EXCLUSION", "ORIGINAL"], [15, "CDISCPILOT01", "TI", "EXCL15", "A history of syncope within the last 5 years.", "EXCLUSION", "ORIGINAL"], [16, "CDISCPILOT01", "TI", "EXCL16", "Evidence from ECG recording at screening of any of the following conditions: a) Left bundle branch block b) Bradycardia <50 beats per minute c) Sinus pauses >2 seconds (See Protocol for Remainder)", "EXCLUSION", "ORIGINAL"], [17, "CDISCPILOT01", "TI", "EXCL17", "A history within the last 5 years of a serious cardiovascular disorder, including a) Clinically significant arrhythmia (See Protocol for Remainder)", "EXCLUSION", "ORIGINAL"], [18, "CDISCPILOT01", "TI", "EXCL18", "A history within the last 5 years of a serious gastrointestinal disorder, including a) Chronic peptic/duodenal/gastric/esophageal ulcer that are untreated or refractory to treatment(See Protocol)", "EXCLUSION", "ORIGINAL"], [19, "CDISCPILOT01", "TI", "EXCL19", "A history within the last 5 years of a serious endocrine disorder, including a) Uncontrolled Insulin Dependent Diabetes Mellitus (IDDM) (See Protocol for other excluded disorders)", "EXCLUSION", "ORIGINAL"], [20, "CDISCPILOT01", "TI", "EXCL20", "A history within the last 5 years of a serious respiratory disorder, including a) Asthma with bronchospasm refractory to treatment b) Decompensated chronic obstructive pulmonary disease.", "EXCLUSION", "ORIGINAL"], [21, "CDISCPILOT01", "TI", "EXCL21", "A history within the last 5 years of a serious genitourinary disorder, including a) Renal failure b) Uncontrolled urinary retention", "EXCLUSION", "ORIGINAL"], [22, "CDISCPILOT01", "TI", "EXCL22", "A history within the last 5 years of a serious rheumatologic disorder, including a) Lupus b) Temporal arteritis c) Severe rheumatoid arthritis", "EXCLUSION", "ORIGINAL"], [23, "CDISCPILOT01", "TI", "EXCL23", "A known history of human immunodeficiency virus (HIV) within the last 5 years.", "EXCLUSION", "ORIGINAL"], [24, "CDISCPILOT01", "TI", "EXCL24", "A history within the last 5 years of a serious infectious disease including a) Neurosyphilis b) Meningitis c) Encephalitis", "EXCLUSION", "ORIGINAL"], [25, "CDISCPILOT01", "TI", "EXCL25", "A history within the last 5 years of a primary or recurrent malignant disease (See Exceptions in Protocol).", "EXCLUSION", "ORIGINAL"], [26, "CDISCPILOT01", "TI", "EXCL26", "Visual, hearing, or communication disabilities impairing the ability to participate in the study; (for example, inability to speak or understand English, illiteracy).", "EXCLUSION", "ORIGINAL"], [27, "CDISCPILOT01", "TI", "EXCL27", "Laboratory test values exceeding the Reference Range III for the patient's age in any of the following analytes: creatinine, total bilirubin, SGOT, SGPT, (See Protocol for Additional Analytes)", "EXCLUSION", "ORIGINAL"], [28, "CDISCPILOT01", "TI", "EXCL28", "Central laboratory test values below reference range for folate, and vitamin B12, and outside reference range for thyroid function tests.", "EXCLUSION", "ORIGINAL"], [29, "CDISCPILOT01", "TI", "EXCL29", "Positive syphilis screening with confirmatory testing.", "EXCLUSION", "ORIGINAL"], [30, "CDISCPILOT01", "TI", "EXCL30", "Central laboratory test value above reference range for glycosylated hemoglobin (A1C) (insulin dependent diabetes mellitus patients only).", "EXCLUSION", "ORIGINAL"], [31, "CDISCPILOT01", "TI", "EXCL31", "Treatment with medications within 1 month prior to enrollment (See Protocol)", "EXCLUSION", "ORIGINAL"], [32, "CDISCPILOT01", "TI", "INCL01", "Males and postmenopausal females at least 50 years of age.", "INCLUSION", "AMENDMENT 1"], [33, "CDISCPILOT01", "TI", "INCL02", "Diagnosis of probable AD as defined by NINCDS and the ADRDA guidelines.", "INCLUSION", "AMENDMENT 1"], [34, "CDISCPILOT01", "TI", "INCL03", "MMSE score of 10 to 23.", "INCLUSION", "AMENDMENT 1"], [35, "CDISCPILOT01", "TI", "INCL04", "Modified Hachinski Ischemic Scale score of <= 4.", "INCLUSION", "AMENDMENT 1"], [36, "CDISCPILOT01", "TI", "INCL05", "CNS imaging (CT scan or MRI of brain) compatible with AD within past 1 year. (See Protocol for incompatible findings.)", "INCLUSION", "AMENDMENT 1"], [37, "CDISCPILOT01", "TI", "INCL06", "Investigator has obtained informed consent signed by the patient (and/or legal representative) and by the caregiver.", "INCLUSION", "AMENDMENT 1"], [38, "CDISCPILOT01", "TI", "INCL07", "Geographic proximity to investigator's site that allows adequate follow-up.", "INCLUSION", "AMENDMENT 1"], [39, "CDISCPILOT01", "TI", "INCL08", "Caregiver will monitor administration of prescribed medications, and will be responsible for the overall care of the patient at home.", "INCLUSION", "AMENDMENT 1"], [40, "CDISCPILOT01", "TI", "EXCL09", "Persons who have previously completed or withdrawn from this study or any other investigating xanomeline TTS or the oral formulation of Zanomaline.", "EXCLUSION", "AMENDMENT 1"], [41, "CDISCPILOT01", "TI", "EXCL10", "Use of any investigational agent or approved Alzheimer's therapeutic medication within 30 days prior to enrollment into the study.", "EXCLUSION", "AMENDMENT 1"], [42, "CDISCPILOT01", "TI", "EXCL11", "Serious illness which required hospitalization within 3 months of screening.", "EXCLUSION", "AMENDMENT 1"], [43, "CDISCPILOT01", "TI", "EXCL12A", "Diagnosis of serious neurological conditions (See Amendment 1)", "EXCLUSION", "AMENDMENT 1"], [44, "CDISCPILOT01", "TI", "EXCL13", "Episode of depression meeting DSM-IV criteria within 3 months of screening.", "EXCLUSION", "AMENDMENT 1"], [45, "CDISCPILOT01", "TI", "EXCL14", "A history within the last 5 years of the following: a) Schizophrenia b) Bipolar Disease c) Ethanol or psychoactive drug abuse or dependence.", "EXCLUSION", "AMENDMENT 1"], [46, "CDISCPILOT01", "TI", "EXCL15", "A history of syncope within the last 5 years.", "EXCLUSION", "AMENDMENT 1"], [47, "CDISCPILOT01", "TI", "EXCL16", "Evidence from ECG recording at screening of any of the following conditions: a) Left bundle branch block b) Bradycardia <50 beats per minute c) Sinus pauses >2 seconds (See Protocol for Remainder)", "EXCLUSION", "AMENDMENT 1"], [48, "CDISCPILOT01", "TI", "EXCL17", "A history within the last 5 years of a serious cardiovascular disorder, including a) Clinically significant arrhythmia (See Protocol for Remainder)", "EXCLUSION", "AMENDMENT 1"], [49, "CDISCPILOT01", "TI", "EXCL18", "A history within the last 5 years of a serious gastrointestinal disorder, including a) Chronic peptic/duodenal/gastric/esophageal ulcer that are untreated or refractory to treatment(See Protocol)", "EXCLUSION", "AMENDMENT 1"], [50, "CDISCPILOT01", "TI", "EXCL19", "A history within the last 5 years of a serious endocrine disorder, including a) Uncontrolled Insulin Dependent Diabetes Mellitus (IDDM) (See Protocol for other excluded disorders)", "EXCLUSION", "AMENDMENT 1"], [51, "CDISCPILOT01", "TI", "EXCL20", "A history within the last 5 years of a serious respiratory disorder, including a) Asthma with bronchospasm refractory to treatment b) Decompensated chronic obstructive pulmonary disease.", "EXCLUSION", "AMENDMENT 1"], [52, "CDISCPILOT01", "TI", "EXCL21", "A history within the last 5 years of a serious genitourinary disorder, including a) Renal failure b) Uncontrolled urinary retention", "EXCLUSION", "AMENDMENT 1"], [53, "CDISCPILOT01", "TI", "EXCL22", "A history within the last 5 years of a serious rheumatologic disorder, including a) Lupus b) Temporal arteritis c) Severe rheumatoid arthritis", "EXCLUSION", "AMENDMENT 1"], [54, "CDISCPILOT01", "TI", "EXCL23", "A known history of human immunodeficiency virus (HIV) within the last 5 years.", "EXCLUSION", "AMENDMENT 1"], [55, "CDISCPILOT01", "TI", "EXCL24", "A history within the last 5 years of a serious infectious disease including a) Neurosyphilis b) Meningitis c) Encephalitis", "EXCLUSION", "AMENDMENT 1"], [56, "CDISCPILOT01", "TI", "EXCL25", "A history within the last 5 years of a primary or recurrent malignant disease (See Exceptions in Protocol).", "EXCLUSION", "AMENDMENT 1"], [57, "CDISCPILOT01", "TI", "EXCL26", "Visual, hearing, or communication disabilities impairing the ability to participate in the study; (for example, inability to speak or understand English, illiteracy).", "EXCLUSION", "AMENDMENT 1"], [58, "CDISCPILOT01", "TI", "EXCL27", "Laboratory test values exceeding the Reference Range III for the patient's age in any of the following analytes: creatinine, total bilirubin, SGOT, SGPT, (See Protocol for Additional Analytes)", "EXCLUSION", "AMENDMENT 1"], [59, "CDISCPILOT01", "TI", "EXCL28", "Central laboratory test values below reference range for folate, and vitamin B12, and outside reference range for thyroid function tests.", "EXCLUSION", "AMENDMENT 1"], [60, "CDISCPILOT01", "TI", "EXCL29", "Positive syphilis screening with confirmatory testing.", "EXCLUSION", "AMENDMENT 1"], [61, "CDISCPILOT01", "TI", "EXCL30", "Central laboratory test value above reference range for glycosylated hemoglobin (A1C) (insulin dependent diabetes mellitus patients only).", "EXCLUSION", "AMENDMENT 1"], [62, "CDISCPILOT01", "TI", "EXCL31A", "Treatment with medications within 1 month prior to enrollment a) Anticonvulsants b) Alpha receptor blockers c) Calcium channel blockers that are CNS active (See Amendment 1)", "EXCLUSION", "AMENDMENT 1"]]}}}}